Thrombotic Antiphospholipid Syndrome: A Long Term Follow‐up of Patients With Recurrent Pregnancy Loss and Antiphospholipid Antibodies From the APS 1994 Study
American Journal of Reproductive Immunology · 2026
DOI: 10.1111/aji.70285 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2026. Verfasst von Minami Ashio und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Nagoya City University, Mizuho-ku, Nagoya, Aichi, Japan. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Abortion, Habitual, Antibodies, Antiphospholipid, Thrombosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Mie Medical Center Inabe General Hospital and Gamagori Municipal Hospital, Ministry of Education, Culture, Sports, Science and Technology (MEXT) Promotion of Distinctive Joint Research Center Program.
Abstract (Originalsprache)
Problem There is a paucity of studies on the incidence and predictors of thrombotic antiphospholipid syndrome (APS) after pregnancy in patients with recurrent pregnancy loss (RPL) and antiphospholipid antibodies (aPL). This prospective study aimed to assess the long‐term prognosis, including the occurrence of thrombosis and associated risk factors, in patients with aPL‐positive RPL and related obstetric APS manifestations. Method of Study We examined patients with RPL and related obstetric APS manifestations who were positive for lupus anticoagulant (LA) based on APTT, Russell's viper venom time (RVVT), or β2glycoprotein I‐dependent anticardiolipin antibody (β2GPIaCL) IgG and visited Nagoya City University Hospital from 1994 to 2019. A survey was conducted in 2024 in which patients were asked to complete a questionnaire on the development of APS manifestations based on the American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria.
Results
Data of 259 of 285 patients (90.5%) who responded to the questionnaire were analysed. The median follows‐up duration was 17 (4.6–31.1) years. Cumulatively, 9.6% (25/259) of patients with aPLs and 15.7% (18/114) of those with obstetric APS experienced thrombotic APS. LA‐APTT, LA‐RVVT, and β2GPIaCL IgG were independent predictors of thrombotic APS, with area under the curve values of 0.85 (0.73–0.97), 0.93 (0.87–0.99), and 0.80 (0.68–0.93), respectively. A history of intrauterine foetal death, early‐onset preeclampsia, no live birth, thrombosis and complications of systematic lupus erythematosus, and persistent aPL were predictive of thrombotic APS.
Conclusion
Patients with RPL and aPL who exhibit the identified risk factors should undergo subsequent follow‐up after pregnancy. Further research is required to investigate the potential for thrombosis prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Nagoya City University, Mizuho-ku, Nagoya, Aichi, Japan.
- Division of Biomedical Sciences, Clinical Science Research Laboratories, Warwick Medical School, University of Warwick, Warwick, Coventry, UK.
- Division of Cancer Information and Control, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
- Sugiura Mayumi Recurrent Pregnancy Loss Clinic, Mizuho-ku, Nagoya, Aichi, Japan.
ORCID-Profile: Shinobu Goto, Mayumi Sugiura-Ogasawara
Förderung
- Mie Medical Center Inabe General Hospital and Gamagori Municipal Hospital
- Ministry of Education, Culture, Sports, Science and Technology (MEXT) Promotion of Distinctive Joint Research Center Program
Zitieren
APA
Ashio, M., Kitaori, T., Yano, Y., Banno, C., Ide, S., Yoshihara, H., Goto, S., Otani, T., & Sugiura-Ogasawara, M. (2026). Thrombotic Antiphospholipid Syndrome: A Long Term Follow‐up of Patients With Recurrent Pregnancy Loss and Antiphospholipid Antibodies From the APS 1994 Study. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70285
Vancouver
Ashio M, Kitaori T, Yano Y, Banno C, Ide S, Yoshihara H, et al. Thrombotic Antiphospholipid Syndrome: A Long Term Follow‐up of Patients With Recurrent Pregnancy Loss and Antiphospholipid Antibodies From the APS 1994 Study. American Journal of Reproductive Immunology. 2026. doi:10.1111/aji.70285
BibTeX
@article{Ashio2026,
author = {Ashio, Minami and Kitaori, Tamao and Yano, Yoshitaka and Banno, Chihiro and Ide, Shoko and Yoshihara, Hiroyuki and Goto, Shinobu and Otani, Takahiro and Sugiura-Ogasawara, Mayumi},
title = {Thrombotic Antiphospholipid Syndrome: A Long Term Follow‐up of Patients With Recurrent Pregnancy Loss and Antiphospholipid Antibodies From the APS 1994 Study},
journal = {American Journal of Reproductive Immunology},
year = {2026},
doi = {10.1111/aji.70285}
}
EUVIMED